Twitter Beğeni Hilesi

In patients with lung cancer, neoadjuvant treatment with nivolumab and chemotherapy resulted in a significantly higher percentage of patients with a pathological complete response than chemotherapy alone. nej.md/3pjpj63

💫 Congratulations to all the awardees winners in #WCLC23. Fernando Lopez-Rios well deserved winner of the Mary J. Matthews Pathology/Translational Research Award 👏👏. A great honor to be part of your team 👌 IASLC Esther Conde MD, PhD

Princess Margaret Cancer Centre looking forward to Cancer Genomics - Tumor Immunotherapy Program Annual Symposium on Friday Nov 10 in MaRS auditorium. Amazing line up of speakers 👏🔥 pm-genomics-IO-symposium.ca

🎉Congratulations to our Senior Scientist Dr. Lillian Siu University Health Network on becoming the 2024-2025 President-Elect for AACR. Siu will be the first Canadian holding this role. She has made outstanding contributions to advance anticancer drug development. >> bit.ly/3TBiQPX

Honoured to pose with ASCO CEO at the end of the opening plenary and with the 🍁 crowd from Princess Margaret Cancer Centre and friends

🧬 👀 About novel bmks hidden in the non-coding DNA: Can retroelement expression influence IO and viceversa? INSPIREd by incredible supportive mentors Lillian Siu & Dr. Spiliopoulou & the huge effort from Daniel De Carvalho. Thanks @conquecancer for supporting our work! #ASCO24

Had an incredible, immersive week at #AACRMBCO24! A full package of science, lab orientation, grant writing skills, and inspiring careers experiences. Huge thanks to AACR, workshop directors, and MBCO crew for such a great experience. Hope to see this team again soon! 🙌🏼

Proud to see our #BispecificAntibodies review out and even more of the process behind it. A round-the-world 🇨🇦🇦🇺🇪🇸collaboration w/ such an incredible team and the mentorship of leading experts in #DrugDevelopment! Check it out 👇🏼